Semma Therapeutics, Brigham and Women’s Hospital, Dana-Farber Cancer Institute, Harvard, Joslin Diabetes Center endocrine/metabolic news

Harvard’s Harvard Stem Cell Institute, Brigham and Women’s Hospital, Joslin Diabetes Center, Semma Therapeutics and Dana-Farber Cancer Institute partnered to form the Boston Autologous Islet Replacement Program (BAIRT) to cure diabetes, focusing on discovering and developing stem cell therapies. ...